申请人:Pfizer Inc.
公开号:US05712303A1
公开(公告)日:1998-01-27
The pyrazoles and pyzazolopyrimidines of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 and A are as defined herein, have corticotropin releasing factor (CRF) antagonist activity. As such, they are effective in the treatment of a wide range of diseases including stress-related illnesses.
公式为##STR1##中的吡唑和吡唑吡嘧啶,其中R.sub.1、R.sub.2、R.sub.3、R.sub.4和A的定义如本文所述,具有促肾上腺皮质激素释放因子(CRF)拮抗剂活性。因此,它们在治疗包括与压力相关的疾病在内的广泛疾病方面是有效的。